Published in Blood Weekly, August 30th, 2007
"The value of the Taiwan market is tremendous," stated Michael Chermak, Chairman and CEO of Bridgetech. "The alliances with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.